ARDELYX, INC. Shareholders' Equity
ARDELYX, INC. (ARDX) had Shareholders' Equity of $149.01 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $149.01M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $148.62M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $166.95M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $154.28M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $149.01M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $148.62M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $166.95M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $154.28M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $139.53M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $145.68M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $173.29M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $158.30M 10-Q · filed 2025-10-30 | |
| 2024-06-30 | $146.99M 10-Q · filed 2025-10-30 | |
| 2024-03-31 | $150.89M 10-Q · filed 2025-08-04 | |
| 2023-12-31 | $166.82M 10-K · filed 2026-02-19 | |
| 2023-09-30 | $191.16M 10-Q · filed 2024-10-31 | |
| 2023-06-30 | $123.16M 10-Q · filed 2024-10-31 | |
| 2023-03-31 | $125.42M 10-Q · filed 2024-08-01 | |
| 2022-12-31 | $98.33M 10-K · filed 2026-02-19 | |
| 2022-09-30 | $66.86M 10-Q · filed 2023-10-31 | |
| 2022-06-30 | $53.04M 10-Q · filed 2023-10-31 | |
| 2022-03-31 | $64.19M 10-Q · filed 2023-08-02 | |
| 2021-12-31 | $82.62M 10-K · filed 2025-02-20 | |
| 2021-09-30 | $81.43M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $117.57M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $130.81M 10-Q · filed 2022-08-04 | |
| 2020-12-31 | $126.11M 10-K · filed 2024-02-22 | |
| 2020-09-30 | $131.34M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $146.35M 10-Q · filed 2021-11-12 | |
| 2020-03-31 | $167.76M 10-Q · filed 2021-08-13 | |
| 2019-12-31 | $186.66M 10-K · filed 2023-03-02 | |
| 2019-09-30 | $49.16M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $68.62M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $91.84M 10-Q · filed 2020-08-06 | |
| 2018-12-31 | $115.81M 10-K · filed 2022-02-28 | |
| 2018-09-30 | $141.45M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $163.41M 10-Q · filed 2019-11-06 | |
| 2018-03-31 | $128.97M 10-Q · filed 2019-08-09 | $128.98M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $139.31M 10-K · filed 2021-03-08 | |
| 2017-09-30 | $126.64M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $144.98M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $167.68M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $193.15M 10-K · filed 2020-03-06 | |
| 2016-09-30 | $222.89M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $140.60M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $167.75M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $108.90M 10-K · filed 2019-03-06 | |
| 2015-09-30 | $125.13M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $142.26M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $58.00M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $60.68M 10-K · filed 2018-03-14 | |
| 2014-09-30 | $63.30M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $62.87M 10-Q · filed 2014-08-08 | |
| 2013-12-31 | -$63.48M 10-K · filed 2017-02-17 | |
| 2012-12-31 | -$57.39M 10-K · filed 2016-03-04 | |
| 2011-12-31 | -$48.26M 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |